耿涛,李亚,刘斯静,张之灜,王炳勋,张建刚,戴士鹏,刘永兴,徐泽升

• 1:河北省沧州市中心医院心内二科
• 2:河北医科大学

摘要(Abstract)：

目的结合实验室检测肌钙蛋白Ⅰ与心电图aVR导联ST段抬高情况,探讨二者在非ST段抬高型急性冠状动脉综合征患者的预后评估中的价值。方法入选非ST段抬高型急性冠状动脉综合征患者255例,采血检验肌钙蛋白Ⅰ,并详细测量心电图AVR导联ST段抬高情况,均行冠脉造影,根据具体情况分别行冠脉介入治疗、冠脉搭桥手术及药物保守治疗,随访6个月,观察终点为不良心血管事件,包括心肌梗死(包括再梗)、心血管死亡和血运重建。结果在随访的6个月内,肌钙蛋白Ⅰ值(OR=7.01,95%CI=1.22～12.63,P=0.02)和aVR导联ST段抬高值(OR=1.38,95%CI=1.084～1.751,P=0.009)是患者发生死亡和心肌梗死(包括再梗)的独立危险因素;同时,肌钙蛋白Ⅰ值(OR=1.249,95%CI=1.114～1.501,P<0.01)和aVR导联ST段抬高值(OR=2.03,95%CI=1.20～4.29,P=0.04)亦是患者不良心血管事件(包括死亡、心肌梗死及血运重建术)发生的独立危险因素。在NSTE-ACS患者中,肌钙蛋白Ⅰ的升高的同时aVR导联ST段抬高者,其左主干病变或三支冠状动脉血管病变发生,以及不良心血管事件(包括死亡、心肌梗死、再梗、血运重建)的发生均是最高的。结论在临床中结合肌钙蛋白Ⅰ和心电图aVR导联ST段变化,可以早期应用于非ST段抬高型急性冠状动脉综合征患者预后的判断。

关键词(KeyWords)： 肌钙蛋白Ⅰ;aVR导联ST段抬高;非ST段抬高型急性冠状动脉综合征;预后

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 耿涛,李亚,刘斯静,张之灜,王炳勋,张建刚,戴士鹏,刘永兴,徐泽升

参考文献(References)：

• [1]Ottani F,Galvani M,Nicolini FA,et al.Elevated cardiac tropo-nin levels predict the risk of adverse outcome in patients with a-cute coronary syndromes.Am Heart J,2000,140:917-927.
• [2]Antman EM,Tanasijevic MJ,Thompson B,et al.Cardiac-spe-cific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.N Engl J Med,1996,335:1342-1349.
• [3]Kaul P,Fu Y,Chang W,et al.Prognostic value of STsegment depression in acute coronary syndromes:insights from PARA-GON-A applied to GUSTO-Ⅱb.J Am Coll Cardiol,2001,38:64-71.
• [4]Holmvang L,Clemmensen P,Lindahl B,et al.Quantitative a-nalysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment.J Am Coll Cardiol,2003,41:905-915.
• [5]Kaul P,Newby LK,Fu Y,et al.Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients.J Am Coll Cardiol,2003,41:371-380.
• [6]Barrabes JA,Figueras J,Moure C,et al.Prognostic value of lead aVR in patients with a first non-ST-segment elevation acute myocardial infarction.Circulation,2003,108:814-819.
• [7]Kosuge M,Kimura K,Ishikawa T,et al.Predictors of left main or three-vessel disease in patients who have acute coronary syn-dromes with non-ST-segment elevation.Am J Cardiol,2005,95:1366-1369.
• [8]李亚,宋志远,耿涛,等.心电图aVR导联ST段抬高对于急性非ST段抬高型冠状动脉综合征患者危险分层的意义.中国介入心脏病学杂志,2009,17:223-225.
• [9]Babuin L,Jaffe AS.Troponin:the biomarker of choice for the detection of cardiac injury.CMAJ,2005,173:1191-1202.
• [10]Apple FS,Smith SW,Pearce LA,et al.Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse e-vents in patients presenting with symptoms suggestive of acute coronary syndrome.Clin Chem,2008,54:723-728.
• [11]Gorgels AP,Vos MA,Mulleneers R,et al.Value of the electro-cardiogram in diagnosing the number of severely narrowed coro-nary arteries in rest angina pectoris.Am J Cardiol,1993,72:999-1003.
• [12]Gaitonde RS,Sharma N,Ali-Hasan S,et al.Prediction of sig-nificant left main coronary artery stenosis by the12-lead electro-cardiogram in patients with rest angina pectoris and the withhol-ding of clopidogrel therapy.Am J Cardiol,2003,92:846-848.
• [13]Szymaski FM,Grabowski M,Filipiak KJ,et al.Admission ST-segment elevation in lead aVR as the factor improving complex risk stratification in acute coronary syndromes.Am J Emer Med,2008,26:408-412.
• [14]Kosuge M,Ebina T,Hibi K,et,al.ST-segment elevation reso-lution in lead aVR:a strong predictor of adverse outcomes in pa-tients with non-ST-segment elevation acute coronary syndrome.Circ J,2008,72:1047-1053.